Trial Profile
Sorafenib combined with percutaneous radio-frequency ablation of both hepatocellular carcinoma nodule and portal vein tumor thrombus compared with sorafenib alone: a western randomized controlled trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Nov 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer; Liver cirrhosis
- Focus Therapeutic Use
- 01 Nov 2016 Results published in the Anticancer Research
- 11 Aug 2016 New trial record